临床试验数据收集：少即是多。 - Suppr

Suppr

超能文献

Clinical trials data collection: when less is more.

作者信息

Sargent Daniel J, George Stephen L

出版信息

J Clin Oncol. 2010 Dec 1;28(34):5019-21. doi: 10.1200/JCO.2010.31.7024. Epub 2010 Oct 4.

DOI:10.1200/JCO.2010.31.7024

PMID:20921455

Abstract

摘要

相似文献

Clinical trials data collection: when less is more.

J Clin Oncol. 2010 Dec 1;28(34):5019-21. doi: 10.1200/JCO.2010.31.7024. Epub 2010 Oct 4.

Clinical trials and drug approvals continue to accelerate in China.

Lancet Oncol. 2017 Jul;18(7):855. doi: 10.1016/S1470-2045(17)30406-0. Epub 2017 May 25.

Research outcomes and recommendations for the assessment of progression in cancer clinical trials.

J Biopharm Stat. 2013;23(5):949-50. doi: 10.1080/10543406.2013.813718.

On the need to adjust for multiplicity in confirmatory clinical trials with master protocols.

Ann Oncol. 2019 Apr 1;30(4):506-509. doi: 10.1093/annonc/mdz038.

NCI's cancer therapy evaluation program: a commitment to treatment trials.

Cancer Treat Res. 2007;132:31-50. doi: 10.1007/978-0-387-33225-3_3.

New EU trial reporting regulations must be enforced.

BMJ. 2022 Feb 18;376:o410. doi: 10.1136/bmj.o410.

The impact of regulations, tradition, and experimental design on clinical cancer trials: report and recommendations resulting from Washington Cancer Trials Conference.

Am J Clin Oncol. 1996 Aug;19(4):325-9. doi: 10.1097/00000421-199608000-00001.

Cancer research and clinical trial in action: an important exercise before you embark on your study.

Cancer Treat Res. 2007;132:291-309. doi: 10.1007/978-0-387-33225-3_16.

Getting the "balance" right in clinical trials.

BMJ. 2021 Nov 24;375:n2869. doi: 10.1136/bmj.n2869.

The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs.

Oncologist. 2017 Sep;22(9):1015-1019. doi: 10.1634/theoncologist.2017-0153. Epub 2017 Jun 15.

引用本文的文献

Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies.

J Natl Cancer Inst. 2025 Mar 1;117(3):396-401. doi: 10.1093/jnci/djae239.

Opportunities and challenges in using real-world data for health care.

J Clin Invest. 2020 Feb 3;130(2):565-574. doi: 10.1172/JCI129197.

Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities.

Clin Cancer Res. 2016 Feb 1;22(3):553-9. doi: 10.1158/1078-0432.CCR-15-0339. Epub 2015 Aug 31.

The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trials.

Clin Cancer Res. 2012 Oct 1;18(19):5179-87. doi: 10.1158/1078-0432.CCR-12-0726. Epub 2012 Jul 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验